ATE531697T1 - Neuartige imidazolinylmethyl-aryl-sulfonamide - Google Patents

Neuartige imidazolinylmethyl-aryl-sulfonamide

Info

Publication number
ATE531697T1
ATE531697T1 AT09708902T AT09708902T ATE531697T1 AT E531697 T1 ATE531697 T1 AT E531697T1 AT 09708902 T AT09708902 T AT 09708902T AT 09708902 T AT09708902 T AT 09708902T AT E531697 T1 ATE531697 T1 AT E531697T1
Authority
AT
Austria
Prior art keywords
novel
methyl aryl
aryl sulfonamides
imidazolinyl
imidazolinyl methyl
Prior art date
Application number
AT09708902T
Other languages
English (en)
Inventor
Counde O'yang
Dennis Mitsugu Yasuda
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE531697T1 publication Critical patent/ATE531697T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT09708902T 2008-02-04 2009-01-26 Neuartige imidazolinylmethyl-aryl-sulfonamide ATE531697T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2583608P 2008-02-04 2008-02-04
PCT/EP2009/050837 WO2009098133A1 (en) 2008-02-04 2009-01-26 Novel imidazolinylmethyl aryl sulfonamides

Publications (1)

Publication Number Publication Date
ATE531697T1 true ATE531697T1 (de) 2011-11-15

Family

ID=40456344

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09708902T ATE531697T1 (de) 2008-02-04 2009-01-26 Neuartige imidazolinylmethyl-aryl-sulfonamide

Country Status (12)

Country Link
US (1) US20090197933A1 (de)
EP (1) EP2238115B1 (de)
JP (1) JP2011511023A (de)
KR (1) KR20100096266A (de)
CN (1) CN101925579A (de)
AT (1) ATE531697T1 (de)
AU (1) AU2009211503A1 (de)
BR (1) BRPI0907495A2 (de)
CA (1) CA2711724A1 (de)
IL (1) IL206763A0 (de)
MX (1) MX2010008019A (de)
WO (1) WO2009098133A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115884964A (zh) * 2020-08-27 2023-03-31 库拉森疗法公司 α1A-肾上腺素能受体激动剂和使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
BR0309668A (pt) * 2002-04-23 2005-03-01 Hoffmann La Roche Imidazolinilmetil aralquilsulfonamidas

Also Published As

Publication number Publication date
US20090197933A1 (en) 2009-08-06
MX2010008019A (es) 2010-08-10
WO2009098133A1 (en) 2009-08-13
JP2011511023A (ja) 2011-04-07
CA2711724A1 (en) 2009-08-13
AU2009211503A1 (en) 2009-08-13
KR20100096266A (ko) 2010-09-01
EP2238115B1 (de) 2011-11-02
BRPI0907495A2 (pt) 2019-02-26
CN101925579A (zh) 2010-12-22
EP2238115A1 (de) 2010-10-13
IL206763A0 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
MX390264B (es) Antagonistas d2, metodos de sintesis y metodos de uso.
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
EA201001724A1 (ru) Производные изоксазола и их применение в качестве потенциирующих средств для метаботропных глутаматных рецепторов
ATE517882T1 (de) Chinolinderivate
EA201390766A1 (ru) БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПОЛУЧЕНИЯ
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
CY1119357T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν συνδετες υποδοχεων σιγμα
UA112317C2 (uk) Похідні 2-(1,2,3-триазол-2-іл)бензаміду та 3-(1,2,3-триазол-2-іл)піколінаміду як антагоністи рецептора орексину
EA201291217A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ 1-(β-D-ГЛЮКОПИРАНОЗИЛ)-2-ТИЕНИЛМЕТИЛБЕНЗОЛА КАК ИНГИБИТОРЫ НЗПГ
DE602006006712D1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
EA200970341A1 (ru) Пиразолиновые соединения в качестве антагонистов минералокортикоидных рецепторов
EA201390163A1 (ru) Гетеробициклические производные в качетстве ингибиторов hcv
EA201300436A8 (ru) Совместные кристаллы и соли ингибиторов ccr3
ATE552246T1 (de) Substituierte aryloxy-n- bicyclomethylacetamidverbindungen als vr1- antagonisten
EA201391524A1 (ru) Производные гликозида и их применение
ATE512142T1 (de) Pyrimidin- und chinazolinderivate als modulatoren der somatostatin-rezeptor aktivität
EA201001566A1 (ru) Новый класс спиропиперидинов для лечения нейродегенеративных заболеваний
ATE495159T1 (de) Diaminocyclohexan- und diaminocyclopentanderivate
EA201290534A1 (ru) Бициклические тиазолы в качестве аллостерических модуляторов mglur5 рецепторов
MA32479B1 (fr) Compoés nouveaux actifs comme antagonistes des recepteurs muscariniques
EA201270556A1 (ru) Конденсированные тиазоло и оксазолопиримидиноны
ATE525360T1 (de) Neuartige imidazolinylmethyl-aryl-sulfonamide
ATE546448T1 (de) Urotensin-ii-rezeptorantagonisten
EA201390488A1 (ru) Новые агонисты gpr 119
DE602007005387D1 (de) Ptors